Imaging-based characterization of the COPDGene cohort

COPDGene 队列的基于成像的表征

基本信息

  • 批准号:
    9127347
  • 负责人:
  • 金额:
    $ 71.06万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-09-01 至 2019-05-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The global mortality of chronic obstructive pulmonary disease (COPD) continues to rise. Unfortunately, the predominant techniques for assessing its progression exhibit important shortcomings. Spirometry, the most commonly used surrogate marker in clinical trials, offers only global indications of functional alteration, and it has encountered substantial difficulty in sensitively and specifically assessing the heterogeneous abnormalities associated with COPD. While computed tomography (CT) produces excellent high-resolution images of key regional abnormalities, most of these images are anatomic and only indirectly related to physiology, and the exposure of patients to ionizing radiation can proscribe its use in longitudinal studies. To address these drawbacks, this project aims to refine and test a hyperpolarized gas magnetic resonance imaging (HP gas MRI) approach for the measurement of several important aspects of COPD pathophysiology in human subjects. The proposed method will allow for the simultaneous obtainment of three regional parameters that together offer a nuanced body of data on pulmonary physiology and microstructure: specific ventilation (SV), alveolar partial pressure of oxygen (pAO2), and apparent diffusion coefficient (ADC). The ability to extract all three of these metrics in a single acquisition period over multipe breaths confers several advantages. Most importantly, the use of a multi-breath sequence leads to more physiologically meaningful measurements. The simultaneous technique also results in inherent co-registration of all three parameters. Once the multi-breath HP MRI approach has been optimized, we will use it to study pulmonary function and structure in 120 COPD patients recruited from the Temple cohort of the COPDGene study. This cohort has already been well characterized by CT and spirometry. Our research on these subjects will first focus on correlating HP MRI metrics with these more established techniques. We will then compare HP MRI parameters with CT parameters in terms of their ability to predict whole-lung functional change, exacerbation frequency, and emphysematous remodeling over a two-year follow-up period. The broad impact of this research will be the development of a technique that can simultaneously derive multiple non-invasive markers of obstructive lung disease. These metrics will supply important physiologic data on the development and progression of COPD that will make a valuable contribution to the ongoing effort to better phenotype this protean disease. The parameters will also provide safe and sensitive markers for longitudinal studies of novel COPD therapies.
 描述(由申请人提供):慢性阻塞性肺疾病(COPD)的全球死亡率持续上升。不幸的是,用于评估其进展的主要技术表现出重要的缺点。肺功能测定法是临床试验中最常用的替代指标,仅提供功能改变的总体指征,在敏感和特异性评估与COPD相关的异质性异常方面遇到了很大的困难。虽然计算机断层扫描(CT)产生关键区域异常的出色的高分辨率图像,但这些图像中的大多数是解剖学的,仅与生理学间接相关,并且患者暴露于电离辐射可能禁止其在纵向研究中使用。为了解决这些缺点,本项目旨在完善和测试超极化气体磁共振成像(HP气体MRI)方法,用于测量人类受试者COPD病理生理学的几个重要方面。所提出的方法将允许同时获得三个区域参数,这些参数一起提供关于肺生理学和微观结构的细微差别的数据:比通气量(SV)、肺泡氧分压(pAO2)和表观扩散系数(ADC)。在多次呼吸的单个采集周期中提取所有这三个度量的能力赋予了几个优点。最重要的是,多呼吸序列的使用导致更有生理意义的测量。同时技术还导致所有三个参数的固有共配准。一旦多呼吸HP MRI方法得到优化,我们将使用它来研究从COPDGene研究的Temple队列招募的120名COPD患者的肺功能和结构。该队列已经通过CT和肺量测定法得到了很好的表征。我们对这些主题的研究将首先集中在将HP MRI指标与这些更成熟的技术相关联。然后,我们将比较HP MRI参数与CT参数在预测全肺功能变化、加重频率和肺气肿重塑方面的能力。这项研究的广泛影响将是开发一种技术,可以同时获得阻塞性肺疾病的多种非侵入性标志物。这些指标将提供关于COPD的发展和进展的重要生理数据,这将对正在进行的改善这种多变疾病的表型的努力做出有价值的贡献。这些参数还将为新型COPD治疗的纵向研究提供安全和敏感的标志物。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RAHIM R RIZI其他文献

RAHIM R RIZI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RAHIM R RIZI', 18)}}的其他基金

Imaging the functional response of the lung to bronchoscopic lung volume reduction
成像肺对支气管镜肺减容的功能反应
  • 批准号:
    10528137
  • 财政年份:
    2022
  • 资助金额:
    $ 71.06万
  • 项目类别:
Imaging the functional response of the lung to bronchoscopic lung volume reduction
成像肺对支气管镜肺减容的功能反应
  • 批准号:
    10680458
  • 财政年份:
    2022
  • 资助金额:
    $ 71.06万
  • 项目类别:
Predicting the onset of chronic rejection in lung transplant recipients using hyperpolarized 129Xe imaging
使用超极化 129Xe 成像预测肺移植受者慢性排斥反应的发生
  • 批准号:
    10192820
  • 财政年份:
    2020
  • 资助金额:
    $ 71.06万
  • 项目类别:
The sixth international workshop on metabolic imaging
第六届代谢影像国际研讨会
  • 批准号:
    10063645
  • 财政年份:
    2020
  • 资助金额:
    $ 71.06万
  • 项目类别:
Predicting the onset of chronic rejection in lung transplant recipients using hyperpolarized 129Xe imaging
使用超极化 129Xe 成像预测肺移植受者慢性排斥反应的发生
  • 批准号:
    10407561
  • 财政年份:
    2020
  • 资助金额:
    $ 71.06万
  • 项目类别:
Improving lung transplant outcomes through the use of imaging in a DBD rat model
通过在 DBD 大鼠模型中使用成像来改善肺移植结果
  • 批准号:
    9764471
  • 财政年份:
    2018
  • 资助金额:
    $ 71.06万
  • 项目类别:
Improving lung transplant outcomes through the use of imaging in a DBD rat model
通过在 DBD 大鼠模型中使用成像来改善肺移植结果
  • 批准号:
    10198021
  • 财政年份:
    2018
  • 资助金额:
    $ 71.06万
  • 项目类别:
Prediction and assessment of COPD lung volume reduction outcomes with polarized MRI
使用偏振 MRI 预测和评估 COPD 肺减容结果
  • 批准号:
    9228404
  • 财政年份:
    2016
  • 资助金额:
    $ 71.06万
  • 项目类别:
Prediction and assessment of COPD lung volume reduction outcomes with polarized MRI
使用偏振 MRI 预测和评估 COPD 肺减容结果
  • 批准号:
    9051246
  • 财政年份:
    2016
  • 资助金额:
    $ 71.06万
  • 项目类别:
A New Approach for the Assessment of Pulmonary Inflammation
评估肺部炎症的新方法
  • 批准号:
    9010971
  • 财政年份:
    2015
  • 资助金额:
    $ 71.06万
  • 项目类别:

相似海外基金

Gain-of-function toxicity in alpha-1 antitrypsin deficient type 2 alveolar epithelial cells
α-1 抗胰蛋白酶缺陷型 2 型肺泡上皮细胞的功能获得毒性
  • 批准号:
    10751760
  • 财政年份:
    2024
  • 资助金额:
    $ 71.06万
  • 项目类别:
The role of alveolar macrophages and regulatory pathways in post-transplant lung inflammation.
肺泡巨噬细胞和调节途径在移植后肺部炎症中的作用。
  • 批准号:
    23K08315
  • 财政年份:
    2023
  • 资助金额:
    $ 71.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pilot Studies of PAX3-FOXO1 Fusions Proteins in Alveolar Rhabdomyosarcoma
PAX3-FOXO1 融合蛋白在肺泡横纹肌肉瘤中的初步研究
  • 批准号:
    10726763
  • 财政年份:
    2023
  • 资助金额:
    $ 71.06万
  • 项目类别:
Mechanistic studies of the genetic contribution of desmoplakin to pulmonary fibrosis in alveolar type 2 cells
桥粒斑蛋白对肺泡2型细胞肺纤维化的遗传贡献机制研究
  • 批准号:
    10736228
  • 财政年份:
    2023
  • 资助金额:
    $ 71.06万
  • 项目类别:
Utilizing induced pluripotent stem cells to study the role of alveolar type 2 cell dysfunction in pulmonary fibrosis
利用诱导多能干细胞研究肺泡2型细胞功能障碍在肺纤维化中的作用
  • 批准号:
    10591174
  • 财政年份:
    2023
  • 资助金额:
    $ 71.06万
  • 项目类别:
Novel alveolar mechanisms of hypoxemia in hepatopulmonary syndrome
肝肺综合征低氧血症的新肺泡机制
  • 批准号:
    10718446
  • 财政年份:
    2023
  • 资助金额:
    $ 71.06万
  • 项目类别:
Mechanical signaling through the nuclear membrane in lung alveolar health
通过核膜的机械信号传导影响肺泡健康
  • 批准号:
    10677169
  • 财政年份:
    2023
  • 资助金额:
    $ 71.06万
  • 项目类别:
Injury of blood brain and alveolar-endothelial barriers caused by alcohol and electronic cigarettes via purinergic receptor signaling
酒精和电子烟通过嘌呤受体信号传导引起血脑和肺泡内皮屏障损伤
  • 批准号:
    10638221
  • 财政年份:
    2023
  • 资助金额:
    $ 71.06万
  • 项目类别:
Alveolar Epithelial Cell Dysfunction Induced By Flavored E-Cigarette Aerosols
加味电子烟气雾剂引起的肺泡上皮细胞功能障碍
  • 批准号:
    10770080
  • 财政年份:
    2023
  • 资助金额:
    $ 71.06万
  • 项目类别:
Delineating the role of let-7 microRNA on lung AT2 cell homeostasis, alveolar regeneration, and interstitial lung disease
描述let-7 microRNA对肺AT2细胞稳态、肺泡再生和间质性肺疾病的作用
  • 批准号:
    10634881
  • 财政年份:
    2023
  • 资助金额:
    $ 71.06万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了